NCT06060392View on ClinicalTrials.gov

Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 30, 2023

Primary Completion Date

September 2, 2025

Study Completion Date

November 1, 2025

Conditions
Liver Transplant; ComplicationsDiabete Mellitus
Interventions
DRUG

Semaglutide Pill

Patient will receive oral semaglutide

Trial Locations (1)

122001

RECRUITING

Division Of Endocrinology & Diabetes, Medanta The Medicity, Gurgaon

All Listed Sponsors
lead

Medanta, The Medicity, India

OTHER